
Joel R. Glucksman
Partner
201-896-7095 jglucksman@sh-law.comFirm Insights
Author: Joel R. Glucksman
Date: November 19, 2015
Partner
201-896-7095 jglucksman@sh-law.comOn Oct. 19, Millennium Health LLC, the largest U.S. drug-testing lab, announced that it had prepared to file for Chapter 11 bankruptcy protection by Nov. 10. According to a Bloomberg report, Millennium Health’s decision to seek bankruptcy protection came after it reached an agreement to pay a $256 million settlement to resolve claims made by the federal government that the company misrepresented the need for certain drug testing procedures and offered doctors gifts in exchange for company referrals.
The company has been involved in federal investigations for over four years, which have tied up its finances and substantially hindered its future earnings outlook as a result. According to a Wall Street Journal report, Millennium Health has been in negotiations to hand over control of the company to its senior lenders throughout the federal investigations. In turn, the company’s creditors have been embroiled in their own fights against one another to determine how much each is owed and how much each will receive in Millennium Health’s shares. Until these financial terms are agreed upon, Millennium Health may not be able to produce an agreed restructuring plan, which could delay its filing for Chapter 11 bankruptcy protection.
The federal government investigations against Millennium Health involved allegations that the company inaccurately billed the Centers for Medicare & Medicaid Services. The case was filed in 2014 by the federal government, as well as 29 states and the District of Columbia, while Omni Healthcare Inc. was also was named as a plaintiff. According to the Wall Street Journal, the case was filed against Millennium Health over allegations that it violated the False Claims Act by requiring doctors to order urine, drug and genetic testing that was deemed unnecessary. The federal government alleged that the company misrepresented to doctors the necessity of a $1,800 genetic test for pain management patients. Further, the government also accused Millennium Health of offering free urine drug testing cups to doctors so that the physicians would return the urine to the company for hundreds of dollars of free testing, which violates the Stark law and anti-kickback statute.
As part of its debt restructuring proposal, Millennium Health plans to hand over control of the company to its senior lenders. According to Bloomberg, the company also plans to reach agreement with its lenders on its $1.8 billion term loan, and sent a copy of the restructuring proposal to the U.S. Department of Justice.
In turn, as part of the settlement, Millennium Health must pay its founder James Slattery and TA Associates, its majority shareholders, $50 million. This number is based on the proportion of equity each entity owns in Millennium Health.
The company’s creditors are also required to vote on the proposed bankruptcy plan by Nov. 8. This decision on the company’s Chapter 11 reorganization plan would be confirmed by Dec. 21. Following this decision, Millennium Health would pay the federal government’s $256 million settlement on Dec. 30.
Are you a creditor in a bankruptcy? Have you been sued by a bankrupt? If you have any questions about your rights, please contact me, Joel Glucksman, at 201-806-3364.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Your home is likely your greatest asset, which is why it is so important to adequately protect it. Homeowners insurance protects you from the financial costs of unforeseen losses, such as theft, fire, and natural disasters, by helping you rebuild and replace possessions that were lost While the definition of “adequate” coverage depends upon a […]
Author: Jesse M. Dimitro
Making a non-contingent offer can dramatically increase your chances of securing a real estate transaction, particularly in competitive markets like New York City. However, buyers should understand that waiving contingencies, including those related to financing, or appraisals, also comes with significant risks. Determining your best strategy requires careful analysis of the property, the market, and […]
Author: Jesse M. Dimitro
Business Transactional Attorney Zemel to Spearhead Strategic Initiatives for Continued Growth and Innovation Little Falls, NJ – February 21, 2025 – Scarinci & Hollenbeck, LLC is pleased to announce that Partner Fred D. Zemel has been named Chair of the firm’s Strategic Planning Committee. In this role, Mr. Zemel will lead the committee in identifying, […]
Author: Scarinci Hollenbeck, LLC
Big changes sometimes occur during the life cycle of a contract. Cancelling a contract outright can be bad for your reputation and your bottom line. Businesses need to know how to best address a change in circumstances, while also protecting their legal rights. One option is to transfer the “benefits and the burdens” of a […]
Author: Dan Brecher
What is a trade secret and why you you protect them? Technology has made trade secret theft even easier and more prevalent. In fact, businesses lose billions of dollars every year due to trade secret theft committed by employees, competitors, and even foreign governments. But what is a trade secret? And how do you protect […]
Author: Ronald S. Bienstock
If you are considering the purchase of a property, you may wonder — what is title insurance, do I need it, and why do I need it? Even seasoned property owners may question if the added expense and extra paperwork is really necessary, especially considering that people and entities insured by title insurance make fewer […]
Author: Patrick T. Conlon
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
On Oct. 19, Millennium Health LLC, the largest U.S. drug-testing lab, announced that it had prepared to file for Chapter 11 bankruptcy protection by Nov. 10. According to a Bloomberg report, Millennium Health’s decision to seek bankruptcy protection came after it reached an agreement to pay a $256 million settlement to resolve claims made by the federal government that the company misrepresented the need for certain drug testing procedures and offered doctors gifts in exchange for company referrals.
The company has been involved in federal investigations for over four years, which have tied up its finances and substantially hindered its future earnings outlook as a result. According to a Wall Street Journal report, Millennium Health has been in negotiations to hand over control of the company to its senior lenders throughout the federal investigations. In turn, the company’s creditors have been embroiled in their own fights against one another to determine how much each is owed and how much each will receive in Millennium Health’s shares. Until these financial terms are agreed upon, Millennium Health may not be able to produce an agreed restructuring plan, which could delay its filing for Chapter 11 bankruptcy protection.
The federal government investigations against Millennium Health involved allegations that the company inaccurately billed the Centers for Medicare & Medicaid Services. The case was filed in 2014 by the federal government, as well as 29 states and the District of Columbia, while Omni Healthcare Inc. was also was named as a plaintiff. According to the Wall Street Journal, the case was filed against Millennium Health over allegations that it violated the False Claims Act by requiring doctors to order urine, drug and genetic testing that was deemed unnecessary. The federal government alleged that the company misrepresented to doctors the necessity of a $1,800 genetic test for pain management patients. Further, the government also accused Millennium Health of offering free urine drug testing cups to doctors so that the physicians would return the urine to the company for hundreds of dollars of free testing, which violates the Stark law and anti-kickback statute.
As part of its debt restructuring proposal, Millennium Health plans to hand over control of the company to its senior lenders. According to Bloomberg, the company also plans to reach agreement with its lenders on its $1.8 billion term loan, and sent a copy of the restructuring proposal to the U.S. Department of Justice.
In turn, as part of the settlement, Millennium Health must pay its founder James Slattery and TA Associates, its majority shareholders, $50 million. This number is based on the proportion of equity each entity owns in Millennium Health.
The company’s creditors are also required to vote on the proposed bankruptcy plan by Nov. 8. This decision on the company’s Chapter 11 reorganization plan would be confirmed by Dec. 21. Following this decision, Millennium Health would pay the federal government’s $256 million settlement on Dec. 30.
Are you a creditor in a bankruptcy? Have you been sued by a bankrupt? If you have any questions about your rights, please contact me, Joel Glucksman, at 201-806-3364.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!